Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review (Q36917017)

17 August 2017

0 references

1 reference

title

Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review (English)

1 reference

17 August 2017

0 references

0 references

5

Robert H Dworkin

1 reference

17 August 2017

Amy M Barrett

1

1 reference

17 August 2017

Melanie A Lucero

2

1 reference

17 August 2017

Trong Le

3

1 reference

17 August 2017

Rebecca L Robinson

4

1 reference

17 August 2017

Amy S Chappell

6

1 reference

17 August 2017

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

8 Suppl 2

1 reference

17 August 2017

S50-62

1 reference

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Contemporary management of neuropathic pain for the primary care physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Treatment of symptomatic diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Tricyclic antidepressant use in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Systematic review of topical capsaicin for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

Responsiveness of the SF-36 among veterans with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

The health care costs of diabetic peripheral neuropathy in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00179.X

10.1111/J.1526-4637.2006.00179.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference